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In intensive care medicine, correctly identifying the underlying
cause of illness in patients presenting to critical care units is
often the key to applying a successful therapeutic regimen.
We report on a patient in whom, despite anamnestic hints, the
correct diagnosis was obscured by misleading laboratory results.
A previously healthy male physician aged 36 years presented
to the emergency room because of balance disturbances and
gait problems. These symptoms began a few hours after
ingestion of remarkably bitter tasting mineral water in the
office of the research laboratory. Soon after admission, the
patient became progressively confused and reported visual
hallucinations; his neurological symptoms rapidly worsened.
The findings of initial diagnostic tests, including blood tests,
microbiological and toxicological screening, cranial computed
tomography scanning and magnetic resonance imaging, were
unremarkable. Nevertheless, the patient soon had to be
sedated and intubated to prevent aspiration.
Within the next 24 hours the patient developed multiple organ
failure with renal, liver, respiratory and circulatory failure, and
signs of disseminated intravascular coagulation and rhabdo-
myolysis. Severe sepsis of unknown cause was presumed,
and empirical treatment with antibiotics and a course of
activated  protein C was initiated; clinical management
required high amounts of fluids and catecholamines. Extensive
microbiological tests, including repeated blood and sputum
cultures, serology for leptospira and borrelia, and polymerase
chain reaction for herpes simplex virus DNA, were unfruitful.
On day 3 after admission repeated toxicological examination
of blood samples and the mineral water revealed contami-
nation with acrylamide at high concentrations. Treatment with
antibiotics and activated protein C was immediately
terminated, and therapy with high doses of N-acetylcysteine
was initiated to replenish hepatic glutathione stores. Between
days 4 and 8 cardiac function gradually returned to normal,
and platelet count, coagulation parameters and renal function
also improved. On day 6 the patient was extubated; he
exhibited signs of severe peripheral polyneuropathy with initial
tetraplegia, bilateral affection of the vagal nerve and resulting
laryngoplegia. When he was transferred for further
neurological rehabilitation after 21 days of intensive care, the
patient was still suffering from occasional confusion and
hallucinations and was unable to walk.
Acute acrylamide intoxication in humans is a rare event that
has been reported only once in the literature [1]. The diag-
nosis should be considered in individuals with access to
acrylamide (for instance, those working in molecular labora-
tories) who develop symptoms of central nervous system
disturbances followed by cardiovascular, respiratory and
other organ manifestations [2]. Gas chromatographic tandem
mass spectrometry has been proven to be a sensitive method
for the detection of acrylamide [3]. The clinical picture of
acrylamide intoxication might suggest severe sepsis with
acute onset, but this diagnosis should be challenged as long
as it remains a working hypothesis.
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